针对性铁亡的表观遗传调节:药物开发的新战略
Shengli Ouyang1, Zeyao Zeng1, Jieyi He1
1The First Clinical College, Guangdong Medical University, Zhanjiang, Guangdong, 524023, China.
Journal of pharmaceutical analysis
|January 24, 2025
概括
表观遗传调节影响铁亡,这是一种细胞死亡途径,对疾病进展至关重要. 了解这种联系提供了新的药物开发策略,特别是在向铁灭的癌症治疗中.
科学领域:
- 生物化学 生物化学
- 细胞生物学 细胞生物学
- 分子生物学分子生物学
背景情况:
- 铁亡是一种依赖于铁的细胞死亡途径,由脂质过氧化驱动.
- 表观遗传调节对于疾病的发展和进展至关重要.
- 铁和表观遗传学之间的相互作用是一个勃发展的研究领域,具有治疗潜力.
研究的目的:
- 探索目前关于表观遗传调节和铁亡之间的相互作用的研究.
- 深入研究它们的监管机制.
- 讨论表观遗传修饰调节剂对疾病和癌症治疗的影响.
主要方法:
- 关于铁和表观遗传学的最新研究的文献综述.
- 对影响铁亡途径的表观遗传修饰的分析.
- 针对癌症中的铁亡的表观遗传因素的检查.
主要成果:
- 表观遗传修饰可以显著影响铁亡途径,可能导致器官功能障碍.
- 现有的表观遗传修饰调节剂对各种疾病产生影响.
- 目前正在进行的研究突出显示,表观遗传因素对于向癌症治疗中的铁致死至关重要.
结论:
- 铁和表观遗传学的交集为药物开发提供了新的途径.
- 对铁亡的表观遗传调节的进一步研究对于推进疾病治疗,特别是瘤学的治疗至关重要.
- 通过表观遗传机制向铁亡,为开发新的癌症疗法提供了有希望的策略.
相关概念视频
Necrosis
4.2K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.2K
Covalently Linked Protein Regulators
6.8K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.8K
Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Transducer Mechanism: Nuclear Receptors
1.3K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.3K
Allosteric Regulation
57.5K
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
57.5K


